EDMONTON, ALBERTA–(June 18, 2008) – Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that it has reached agreement with BioSurface Technologies of Bozeman, Montana to market and distribute its patented MBECTM Assay research tool.
“Biofilm research and knowledge have seen dramatic growth over the past five years. BioSurface Technologies is the only company that is focused exclusively on the biofilm market segment” says Nick Allan, Contract Research Manager at Innovotech. “Commercial and academic researchers will both benefit from the convenient availability of this basic technology.”
Bryan Warwood, Vice President of Operations at BioSurface Technologies stated “The MBECTM Assay fills an important customer need in biofilm research for a high throughput screening system. BioSurface Technologies is delighted to offer this technology to our extensive client base.”
About Innovotech Inc:
Innovotech is a product development company focusing on the development of solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are protected communities of microorganisms which are very common and very difficult to treat due to their inherent resistance. They have been implicated in a host of devastating infections in agriculture, human health and industry. No diagnostics or antibiotics are currently approved for use in infections involving biofilms.
About BioSurface Technologies:
BioSurface Technologies Corporation (BST) was founded in 1994 to provide biofilm reactor systems for evaluations and monitoring of biofilm processes. BST is the sole licensed manufacturer of the Center for Biofilm Engineering’s Biofilm Annular Reactor, Rotating Disc Reactor System, and Drip Flow Reactor. BST is located in Bozeman, Montana and has facilities for laboratory evaluations, biofilm process testing, and product assembly.